Eupraxia Share Price

Eupraxia Share Price

NASDAQ: EPRX | Healthcare
$5.82
-$0.28 (-4.59%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Eupraxia Stock Performance

Open
$6.26
Prev. Close
$6.10
Circuit Range
N/A
Day Range
$5.74 - $6.26
Year Range
$5.64 - $9.23
Volume
10,071
Average Traded
$5.88

Eupraxia Share Price Today

As of 21 November 2026, Eupraxia Pharmaceuticals Inc.'s share price is $5.82. The stock opened at $6.26, compared to its previous close of $6.10. During today's trading session, Eupraxia Pharmaceuticals Inc.'s share price traded between $5.74 and $6.26, with an average price of $6.00. Over the past 52 weeks, the stock has recorded a high of $9.23 and a low of $5.64. In terms of performance, Eupraxia Pharmaceuticals Inc.'s share price has declined by 18.09% over the last six months and is down 7.32% on a year-on-year basis.

Eupraxia Share Price Chart

Line chart of the Eupraxia price trend over the selected period. The price fell overall, ranging from 5.71 to 6.26, ending at 5.82.
$5.74$6.26
L
Show Current Price
H

Eupraxia Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Eupraxia Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$25.93-$41.11
Net Profit MarginN/AN/A
Income ChangeN/A-58.54%

Eupraxia Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets1.050.51
Current Assets85.134.44
Total Assets86.1534.94
Non Current Liabilities0.080.0
Current Liabilities5.633.1
Total Liabilities5.73.1
Shareholders' Equity50.710.13

Eupraxia Cash Flow

Annually

All figures in USD Million

Particulars20252024
Operating-28.55-29.99
Investing-0.59-0.08
Financing76.0645.78

About Eupraxia

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs. Currently, the company has two distinct clinical development programs, one targeting EoE and the second targeting chronic Osteoarthritis pain in the knee and has completed a Phase 2b clinical trial with EP-104IAR in knee OA.

Eupraxia Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$6.86
$5.81
-15.24%
Oct 2026
$9.12
$6.86
-24.88%
Sep 2026
$6.34
$9.13
+23.56%
Aug 2026
$6.47
$7.38
+15.39%
Jul 2026
$6.75
$6.40
-2.88%
Jun 2026
$6.98
$6.59
-7.25%
May 2026
$7.89
$7.11
-8.91%
Apr 2026
$7.59
$7.80
+7.59%
Mar 2026
$8.34
$7.25
-10.99%
Feb 2026
$8.20
$8.14
-3.50%
Jan 2026
$7.58
$8.44
+11.13%
Dec 2025
$6.36
$7.59
+20.94%

Eupraxia Share Price FAQs